In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Nick McCooke, CEO of Longas Technologies. Having been at the forefront of developing next generation sequencing, Nick talks to Mike about his past work, current projects and future predictions for this key technology in the life sciences space. He explains the process and journey he went on to trigger the creation of Solexa, which was later acquired by Illumina, and how next generation sequencing developed and transformed the marketplace after this acquisition. Nick also explains the role NGS has played in the development of Covid-19 solutions around the world, including mapping the viral genome and tracking subsequent mutations. They go onto the discuss the long-read sequencing platform Longas Technologies is currently working on and how this could advance NGS even. Nick also gives his predictions on where NGS could go next, and how it’ll continue to develop and benefit the patient. Hosted on Acast. See acast.com/privacy for more information.